Business Description
Joincare Pharmaceutical Group Industry Co Ltd
NAICS : 325411
SIC : 5122
ISIN : CNE000001816
Share Class Description:
SHSE:600380: Class ACompare
Compare
Traded in other countries / regions
600380.ChinaJCARE.SwitzerlandF9L.Germany IPO Date
2001-06-08Description
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.36 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | 1.65 | |||||
| Interest Coverage | 22.97 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.6 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.6 | |||||
| 3-Year EBITDA Growth Rate | 18 | |||||
| 3-Year EPS without NRI Growth Rate | 19.8 | |||||
| 3-Year FCF Growth Rate | 21.6 | |||||
| 3-Year Book Growth Rate | 8.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 85.8 | |||||
| 9-Day RSI | 76.04 | |||||
| 14-Day RSI | 67.41 | |||||
| 6-1 Month Momentum % | -13.08 | |||||
| 12-1 Month Momentum % | 12.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.41 | |||||
| Quick Ratio | 2.12 | |||||
| Cash Ratio | 1.49 | |||||
| Days Inventory | 143.81 | |||||
| Days Sales Outstanding | 66.69 | |||||
| Days Payable | 146.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.45 | |||||
| 3-Year Dividend Growth Rate | -2.1 | |||||
| Forward Dividend Yield % | 1.45 | |||||
| 5-Year Yield-on-Cost % | 1.44 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | -7.77 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.59 | |||||
| Operating Margin % | 19.67 | |||||
| Net Margin % | 8.77 | |||||
| ROE % | 11.75 | |||||
| ROA % | 4.33 | |||||
| ROIC % | 19.05 | |||||
| ROC (Joel Greenblatt) % | 61.52 | |||||
| ROCE % | 14.64 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.6 | |||||
| PE Ratio without NRI | 15.6 | |||||
| Shiller PE Ratio | 21.38 | |||||
| Price-to-Owner-Earnings | 31.29 | |||||
| PS Ratio | 1.37 | |||||
| PB Ratio | 1.81 | |||||
| Price-to-Tangible-Book | 2.09 | |||||
| Price-to-Free-Cash-Flow | 9.93 | |||||
| Price-to-Operating-Cash-Flow | 7.1 | |||||
| EV-to-EBIT | 4.09 | |||||
| EV-to-EBITDA | 4.09 | |||||
| EV-to-Revenue | 0.88 | |||||
| EV-to-FCF | 6.42 | |||||
| Price-to-Projected-FCF | 0.83 | |||||
| Price-to-Median-PS-Value | 0.89 | |||||
| Price-to-Graham-Number | 1.21 | |||||
| Price-to-Net-Current-Asset-Value | 51.63 | |||||
| Earnings Yield (Greenblatt) % | 24.45 | |||||
| Forward Rate of Return (Yacktman) % | 12.56 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Joincare Pharmaceutical Group Industry Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 17,297.549 | ||
| EPS (TTM) (Â¥) | 0.794 | ||
| Beta | 0.72 | ||
| Volatility % | 25.16 | ||
| 14-Day RSI | 67.41 | ||
| 14-Day ATR (Â¥) | 0.225985 | ||
| 20-Day SMA (Â¥) | 11.844 | ||
| 12-1 Month Momentum % | 12.33 | ||
| 52-Week Range (Â¥) | 10.09 - 14.24 | ||
| Shares Outstanding (Mil) | 1,911.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Joincare Pharmaceutical Group Industry Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Joincare Pharmaceutical Group Industry Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Joincare Pharmaceutical Group Industry Co Ltd Frequently Asked Questions
What is Joincare Pharmaceutical Group Industry Co Ltd(SHSE:600380)'s stock price today?
The current price of SHSE:600380 is ¥12.39. The 52 week high of SHSE:600380 is ¥14.24 and 52 week low is ¥10.09.
When is next earnings date of Joincare Pharmaceutical Group Industry Co Ltd(SHSE:600380)?
The next earnings date of Joincare Pharmaceutical Group Industry Co Ltd(SHSE:600380) is .
Does Joincare Pharmaceutical Group Industry Co Ltd(SHSE:600380) pay dividends? If so, how much?
The Dividend Yield %  of Joincare Pharmaceutical Group Industry Co Ltd(SHSE:600380) is 1.45% (As of Today), Highest Dividend Payout Ratio of Joincare Pharmaceutical Group Industry Co Ltd(SHSE:600380) was 0.38. The lowest was 0.11. And the median was 0.25. The  Forward Dividend Yield % of Joincare Pharmaceutical Group Industry Co Ltd(SHSE:600380) is 1.45%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers